PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+28.07%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
71.63%
Holding
34
New
34
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Plains GP Holdings
PAGP
|
$21.9M |
| 2 |
Applied Therapeutics
APLT
|
$18M |
| 3 |
TScan Therapeutics
TCRX
|
$12.2M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$6.95M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$5.87M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 62.69% |
| 2 | Energy | 18.15% |
| 3 | Technology | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Plains GP Holdings
PAGP
$3.82B
| $21.9M | 18.15% | +1,372,360 | New | +$21.9M |
|
|
2
Applied Therapeutics
APLT
$71M
| $18M | 14.93% | +5,374,982 | New | +$18M |
|
|
3
TScan Therapeutics
TCRX
$102M
| $12.2M | 10.09% | +2,087,139 | New | +$12.2M |
|
|
4
Madrigal Pharmaceuticals
MDGL
$9.76B
| $6.95M | 5.76% | +30,032 | New | +$6.95M |
|
|
5
Crinetics Pharmaceuticals
CRNX
$2.92B
| $5.87M | 4.87% | +165,000 | New | +$5.87M |
|
6
Fulcrum Therapeutics
FULC
$351M
| $5.06M | 4.2% | +750,000 | New | +$5.06M |
|
7
Phathom Pharmaceuticals
PHAT
$864M
| $4.05M | 3.35% | +443,047 | New | +$4.05M |
|
8
Day One Biopharmaceuticals
DAWN
$769M
| $3.95M | 3.28% | +270,664 | New | +$3.95M |
|
9
Ardelyx
ARDX
$1.53B
| $3.68M | 3.05% | +594,174 | New | +$3.68M |
|
10
Athira Pharma
ATHA
$15.3M
| $3.63M | 3.01% | +1,492,792 | New | +$3.63M |
|
11
Telesat
TSAT
$307M
| $3.03M | 2.51% | +290,781 | New | +$3.03M |
|
12
Simplify Enhanced Income ETF
HIGH
$191M
| $2.95M | 2.45% | +120,221 | New | +$2.95M |
|
13
Akero Therapeutics
AKRO
$3.74B
| $2.34M | 1.94% | +100,052 | New | +$2.34M |
|
14
Vanguard Short-Term Bond ETF
BSV
$38.5B
| $2.13M | 1.77% | +27,712 | New | +$2.13M |
|
|
IBDP
15
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $2.13M | 1.76% | +85,442 | New | +$2.13M |
|
16
iShares MBS ETF
MBB
$41B
| $2.11M | 1.75% | +22,400 | New | +$2.11M |
|
17
Mirum Pharmaceuticals
MIRM
$3.71B
| $2.07M | 1.71% | +70,000 | New | +$2.07M |
|
|
MRNS
18
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.96M | 1.62% | +180,100 | New | +$1.96M |
|
19
Kura Oncology
KURA
$686M
| $1.87M | 1.55% | +130,000 | New | +$1.87M |
|
20
Avidity Biosciences
RNA
$5.99B
| $1.62M | 1.34% | +178,500 | New | +$1.62M |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $1.43M | 1.19% | +56,359 | New | +$1.43M |
|
22
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.42B
| $1.36M | 1.13% | +45,695 | New | +$1.36M |
|
23
Kayne Anderson Energy Infrastructure Fund
KYN
$2.12B
| $1.29M | 1.07% | +147,033 | New | +$1.29M |
|
|
EIGR
24
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $986K | 0.82% | +4,391,432 | New | +$986K |
|
25
Sutro Biopharma
STRO
$72.7M
| $837K | 0.69% | +195,000 | New | +$837K |
|